These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
296 related items for PubMed ID: 15003789
1. Osteoclastogenesis is decreased by cysteine proteinase inhibitors. Brage M, Lie A, Ransjö M, Kasprzykowski F, Kasprzykowska R, Abrahamson M, Grubb A, Lerner UH. Bone; 2004 Mar; 34(3):412-24. PubMed ID: 15003789 [Abstract] [Full Text] [Related]
2. Cysteine proteinase inhibitors regulate human and mouse osteoclastogenesis by interfering with RANK signaling. Strålberg F, Henning P, Gjertsson I, Kindlund B, Souza PP, Persson E, Abrahamson M, Kasprzykowski F, Grubb A, Lerner UH. FASEB J; 2013 Jul; 27(7):2687-701. PubMed ID: 23572233 [Abstract] [Full Text] [Related]
6. Regulation of osteoclastogenesis by gap junction communication. Matemba SF, Lie A, Ransjö M. J Cell Biochem; 2006 Oct 01; 99(2):528-37. PubMed ID: 16639710 [Abstract] [Full Text] [Related]
8. Inhibition of lipopolysaccharide-induced osteoclast formation and bone resorption in vitro and in vivo by cysteine proteinase inhibitors. Strålberg F, Kassem A, Kasprzykowski F, Abrahamson M, Grubb A, Lindholm C, Lerner UH. J Leukoc Biol; 2017 May 01; 101(5):1233-1243. PubMed ID: 28196851 [Abstract] [Full Text] [Related]
9. Nuclear localization of type I parathyroid hormone/parathyroid hormone-related protein receptors in deer antler osteoclasts: evidence for parathyroid hormone-related protein and receptor activator of NF-kappaB-dependent effects on osteoclast formation in regenerating mammalian bone. Faucheux C, Horton MA, Price JS. J Bone Miner Res; 2002 Mar 01; 17(3):455-64. PubMed ID: 11874237 [Abstract] [Full Text] [Related]
11. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts. Chung YH, Chang EJ, Kim SJ, Kim HH, Kim HM, Lee SB, Ko JS. J Periodontal Res; 2006 Aug 01; 41(4):288-96. PubMed ID: 16827722 [Abstract] [Full Text] [Related]
12. Thyroid hormone stimulates osteoclast differentiation by a mechanism independent of RANKL-RANK interaction. Kanatani M, Sugimoto T, Sowa H, Kobayashi T, Kanzawa M, Chihara K. J Cell Physiol; 2004 Oct 01; 201(1):17-25. PubMed ID: 15281085 [Abstract] [Full Text] [Related]
14. Different cysteine proteinases involved in bone resorption and osteoclast formation. Brage M, Abrahamson M, Lindström V, Grubb A, Lerner UH. Calcif Tissue Int; 2005 Jun 01; 76(6):439-47. PubMed ID: 15906014 [Abstract] [Full Text] [Related]
15. IL-1 alpha stimulates the formation of osteoclast-like cells by increasing M-CSF and PGE2 production and decreasing OPG production by osteoblasts. Tanabe N, Maeno M, Suzuki N, Fujisaki K, Tanaka H, Ogiso B, Ito K. Life Sci; 2005 Jun 24; 77(6):615-26. PubMed ID: 15921993 [Abstract] [Full Text] [Related]
16. Receptor activator of NF-kappaB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Yamaguchi M, Uchiyama S. Int J Mol Med; 2004 Jul 24; 14(1):81-5. PubMed ID: 15202020 [Abstract] [Full Text] [Related]
17. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium. Atkins GJ, Kostakis P, Welldon KJ, Vincent C, Findlay DM, Zannettino AC. J Cell Physiol; 2005 Jun 24; 203(3):573-82. PubMed ID: 15573398 [Abstract] [Full Text] [Related]
18. [Ascorbic acid inhibits the formation and function of osteoclasts from RAW264.7 cells induced by receptor activated nuclear factor kappaB ligand in vitro]. Xiao XH, Zhou HD, Yuan LQ, Xie H, Liao EY. Zhonghua Yi Xue Za Zhi; 2004 Dec 17; 84(24):2102-6. PubMed ID: 15730627 [Abstract] [Full Text] [Related]
19. Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures. Kaji H, Kanatani M, Sugimoto T, Chihara K. Horm Metab Res; 2005 Oct 17; 37(10):589-92. PubMed ID: 16278780 [Abstract] [Full Text] [Related]
20. Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol. Ishizuka K, Hirukawa K, Nakamura H, Togari A. Neurosci Lett; 2005 Apr 29; 379(1):47-51. PubMed ID: 15814197 [Abstract] [Full Text] [Related] Page: [Next] [New Search]